Alya A Aljubran,Jumanah A Almubarak,Kawther H Alawad et al.
Alya A Aljubran et al.
Objective: To assess the heart attack (HA) knowledge, awareness, and attitude among adults in Al-Hasa, Saudi Arabia, and to identify gaps in understanding that could hinder prompt medical intervention. ...
Low Prevalence of Coronary Artery Calcium in High Cardiometabolic Risk Kenyan Adults with and Without HIV: The ASANTE Study [0.03%]
肯尼亚高心血管代谢风险成人冠状动脉钙化患病率低：ASANTE研究
Harini Shah,Srikanth Krishnan,Aditya Narashim et al.
Harini Shah et al.
Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Results [0.03%]
拉丁美洲的免疫与心血管疾病。CorVacc研究结果
Fernando Wyss,Ricardo Lopez-Santi,Daniel Piskorz et al.
Fernando Wyss et al.
Introduction: Immunization rates against influenza and pneumococcus in Latin America remain lower than expected, particularly in Andean region, Central America, Mexico, and Caribbean region. An incremental correlation bet...
Multicenter Study
Global heart. 2025 Dec 5;20(1):108. DOI:10.5334/gh.1496 2025
Income-Based Inequalities in Five-Year Survival after Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention among Formally Employed Adults in Colombia: A Nationwide Cohort Study [0.03%]
基于收入的心脏病患者在哥伦比亚进行冠状动脉旁路移植术后和经皮冠状动脉介入术后的五年生存率差异：一项全国队列研究
Andrés Felipe Patiño-Benavidez,Darío Echeverri,Carlos Eduardo Obando López et al.
Andrés Felipe Patiño-Benavidez et al.
Background: Myocardial revascularization by coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) lowers mortality, yet long-term outcomes may vary by socioeconomic status despite broadly simi...
Multicenter Study
Global heart. 2025 Nov 27;20(1):105. DOI:10.5334/gh.1494 2025
Causal Effects Between Retinal Characteristics and Cardiovascular Diseases: Insights from Genetic Correlation, Mendelian Randomization, and Cross-Sectional Study [0.03%]
遗传相关性、孟德尔随机化和横断面研究揭示的眼睛视网膜特征与心血管疾病之间的因果关系效应
Xuehao Cui,Chao Sun,Dejia Wen et al.
Xuehao Cui et al.
Background: Cardiovascular diseases (CVDs) are the leading global cause of mortality and disability, with prevalence increasing due to aging and risk factors like obesity and hypertension. The retina, rich in microvascula...
The European Program for Prevention (EPP) - Implementing Proven Preventing Measures Now! [0.03%]
欧洲预防项目(EPP)-立即实施行之有效的预防措施！
Maciej Banach,Zlatko Fras,Dan Gaita et al.
Maciej Banach et al.
Cardiovascular diseases (CVDs) remain a leading global cause of mortality and disability, with significant disparities observed across countries. This is particularly true in Central and Eastern Europe (CEE), where populations are primarily...
The Burden and Trends of Degenerative Mitral Valve Disease at the Global, Regional, and National Levels From 1990 to 2021, With Projections to 2035 [0.03%]
1990至2021年全球、区域和国家退行性二尖瓣病变负担及趋势，附2035年前预测值
Qiang Li,Yifan Yang,Zhi-Nan Lu et al.
Qiang Li et al.
Background: Degenerative mitral valve disease (DMVD) is a significant contributor to the global burden of disease. This study aimed to estimate the prevalence, mortality, and disability-adjusted life years (DALYs) rates o...
Multicenter Study
Global heart. 2025 Oct 28;20(1):101. DOI:10.5334/gh.1489 2025
Long-Term Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination for the Treatment of Hypertension [0.03%]
一种新型低剂量单片复方制剂治疗高血压的长期疗效和安全性研究
Abdul Salam,H Asita de Silva,Dike Ojji et al.
Abdul Salam et al.
Background: A novel low-dose triple single-pill combination of antihypertensive drugs (GMRx2) has demonstrated superior blood pressure (BP)-lowering efficacy compared to placebo and dual combinations in short-term randomi...
Randomized Controlled Trial
Global heart. 2025 Oct 31;20(1):102. DOI:10.5334/gh.1481 2025
Systematic Review of Social Marketing as a Behavior Change Agent in Salt Reduction [0.03%]
系统评价：社会营销在减盐行为改变中的作用
Silvia Sommariva,Dove Wimbish,Sarah Mayes et al.
Silvia Sommariva et al.
The use of social marketing (SM) interventions for salt/sodium reduction has drawn increased attention worldwide. This systematic review investigates the application of social marketing principles to the design, implementation, and evaluati...
Correction: Within-Trial Cost-Effectiveness Analysis of a Family-Based Structured Lifestyle Modification Intervention Program for Cardiovascular Risk Reduction: Results from the PROLIFIC Trial [0.03%]
对PROLIFIC试验中基于家庭的结构化生活方式干预项目的疗效和成本效果进行校正：同一试验内心血管疾病风险降低的成本效果分析结果
Ashis Samuel John,Sanjay Ganapathi,Sivadasanpillai Harikrishnan et al.
Ashis Samuel John et al.
[This corrects the article DOI: 10.5334/gh.1450.]. Keywords: Cost-effective analysis; Ischemic heart disease...
Published Erratum
Global heart. 2025 Oct 21;20(1):99. DOI:10.5334/gh.1490 2025